Scarica l'app Stockscreener
8.00
4.31%
-0.36
Precedente Chiudi:
$8.36
Aprire:
$8.33
Volume 24 ore:
16,458
Relative Volume:
0.22
Capitalizzazione di mercato:
$166.65M
Reddito:
-
Utile/perdita netta:
$-24.87M
Rapporto P/E:
-6.0611
EPS:
-1.3199
Flusso di cassa netto:
$-23.65M
1 W Prestazione:
+5.12%
1M Prestazione:
+36.29%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$7.92
$8.44
Intervallo di 1 settimana:
$7.27
$8.59
Portata 52W:
$5.50
$13.39
Satellos Bioscience Inc Stock (MSLE) Company Profile
Nome
Satellos Bioscience Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare MSLE vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MSLE
Satellos Bioscience Inc
|
8.00 | 166.65M | 0 | -24.87M | -23.65M | -1.3199 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Satellos Bioscience Inc Stock (MSLE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-06 | Iniziato | Leerink Partners | Outperform |
| 2026-03-11 | Iniziato | Cantor Fitzgerald | Overweight |
Satellos Bioscience Inc Borsa (MSLE) Ultime notizie
MSLE Stock Price, Quote & Chart | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill
Guggenheim Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $23 - Moomoo
Satellos launches public offering, applies for Nasdaq listing - MSN
Satellos Bioscience (NASDAQ:MSLE) Downgraded by Wall Street Zen to "Strong Sell" - MarketBeat
Satellos prices $50M public offering - MSN
MSLE Satellos Bioscience Inc. reports far wider than expected Q4 2025 loss while its shares post modest gains amid positive investor sentiment.Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Satellos Bioscience (MSLE) Stock: Portfolio Allocation (Bearish Sentiment) 2026-04-20Community Chart Signals - Xã Châu Thành
MSLE : Satellos Bioscience Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
MSLE: Satellos Bioscience Inc.Insider Transations - Zacks Investment Research
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - Investing News Network
Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference - TipRanks
Satellos Bioscience (NASDAQ: MSLE) plans Bloom Burton investor conference presentation - Stock Titan
Satellos CEO, CFO to meet investors in Toronto on April 21 - Stock Titan
Satellos Bioscience (NASDAQ:MSLE) Coverage Initiated by Analysts at Leerink Partners - Defense World
Satellos Bioscience Inc. (NASDAQ:MSLE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Satellos Bioscience (NASDAQ:MSLE) Now Covered by Analysts at Leerink Partners - MarketBeat
Leerink initiates Satellos Bioscience stock with Outperform rating By Investing.com - Investing.com South Africa
MSLE Archives - 24/7 Wall St.
Leerink initiates Satellos Bioscience stock with Outperform rating - Investing.com
Satellos initiated with an Outperform at Leerink - TipRanks
Investment bank Leerink Partners recently released a research report, initiating coverage on biotechnology company Satellos Bioscience Inc. (stock symbol: MSLE) for the first time. - Bitget
Satellos Bioscience Inc. (0IT.SG) Options Chain - Yahoo! Finance Canada
All News for MSLE : Satellos Bioscience Inc. - Zacks Investment Research
MSLE Stock Analysis: Satellos Bioscience Inc. 2.81 pct dip to 5.87 key insights - Cổng thông tin điện tử tỉnh Lào Cai
What date does Satellos Bioscience Inc.'s (MSLE) report EarningsEarnings Calendar & Announcement - zacks.com
Long Term Trading Analysis for (MSCL) (MSCL:CA) - Stock Traders Daily
Brokers Offer Predictions for MSLE FY2030 Earnings - Defense World
FY2030 Earnings Forecast for MSLE Issued By HC Wainwright - MarketBeat
Dividend HistorySatellos Bioscience Inc. (MSLE) - Zacks Investment Research
Satellos Bioscience: 2025 Financial Performance - AlphaStreet
Satellos Bioscience (NASDAQ:MSLE) Releases Earnings Results - MarketBeat
Stocks in play: Satellos Bioscience Inc. - Barchart
Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials - TipRanks
Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Satellos Bioscience: Q4 Earnings Snapshot - marketscreener.com
Satellos Bioscience : Fourth Quarter 2025 Management’s Discussion Analysis - marketscreener.com
Satellos Bioscience (NASDAQ: MSLE) files annual report; 15,458,903 shares - Stock Titan
Satellos Bioscience (MSLE) funds 2027 runway while advancing Phase 2 DMD trials - Stock Titan
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - 富途牛牛
MSLE Earnings History & Surprises | EPS & Revenue Results | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill
MSLE News | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Satellos Bioscience (NASDAQ:MSLE) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Cantor Fitzgerald Initiates Coverage on Satellos Bioscience (NASDAQ:MSLE) - Defense World
(MSCL) Comprehensive Trading Strategy Report (MSCL:CA) - Stock Traders Daily
This Canadian biotech stock will beat the market, analyst says - Cantech Letter
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
Satellos Bioscience Inc Azioni (MSLE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):